Click here for the Free E-book How to Get Off Psychoactive Drugs Safely
Review by Dr. Hyla Cass
M.D. Psychiatrist "Here is
an essential handbook on
how to safely and more
easily wean yourself (under
medical supervision) off the
psychotropic medications. I
have used the program with
my patients and it works!”
Hyla Cass M.D. Author of
The latest edition of How to
Get Off Psychotropic
Drugs Safely, is now
available as an e-book and
at Amazon.com. This
bestselling book details
what to do to avoid Prozac
withdrawal side effects,
what you can do to
eliminate existing Prozac
withdrawal side effects and
how to reduce the Prozac
safely. Click here for the
E-book which allows you
to receive the book
The physician’s psychoactive medication resource guide
25% of your patients taking an antidepressant will have
weight gain and the weight gain is directly caused by the antidepressant.
Zoloft withdrawal. Zoloft withdrawal side effects, Zoloft withdrawal warnings, Zoloft
withdrawal precautions, Zoloft withdrawal adverse effects, overdose, withdrawal
symptoms and Zoloft natural alternatives. Before you begin the spiral down with Zoloft,
try giving your body what it really wants.
While taking Zoloft or discontinuing Zoloft several adverse reactions occur. They can range
from anxiety/insomnia to fatigue and debilitating head symptoms. The book How to Get Off
Psychoactive Drugs Safely by James Harper N.C. describes in detail what to do for your
patients. Your patients will also be able to take the step-by-step instructions found in this book
and put them to use instantly. This book is written for physicians, pharmacists and patients.
You can click here and read the book in full and for free at The Road Back.
Body aches and pains, nausea and other side effects caused by Zoloft withdrawal does not
need to happen.
SSRI Antidepressants May Up Stroke Risk After Menopause
Date Published: Thursday, December 17th, 2009
Post-menopausal women taking selective serotonin reuptake inhibitor (SSRI) antidepressants
have a small, though statistically higher risk of stroke, according to a newly published study.
SSRIs include the drugs Prozac, Paxil, Zoloft, Lexapro, and Celexa.
Antidepressant use in the US has more than quintupled since the early 1990s, and SSRIs
have replaced older medications called tricyclic antidepressants, which can be toxic the
heart. According to a press release announcing this latest study, SSRI antidepressants have
fewer side effects in general and are known to have aspirin-like effects on bleeding, which
could protect against clot-related cardiovascular disorders. But not much is known about how
SSRIs affect the heart. This is especially true in the case of postmenopausal women, who are
at increased risk for both heart disease and depression.
The study, which was published in the December 14 Archives of Internal Medicine, involved
136,000 participants in the Women’s Health Initiative (WHI). None of the women were taking
antidepressants when they enrolled in the WHI.
The women included in the analysis had their first follow-up visit either one or three years
after enrolling in WHI. At that time, 5,500 women reported taking either tricyclic or SSRI
antidepressants. After six years, there was no association between antidepressant use and
heart disease. However, researchers did find that women taking SSRIs had a 45 percent
increase in risk of stroke and a 32 percent increase in risk of dying from any cause during
follow up, compared with nonusers. Use of older tricyclic antidepressants wasn’t linked to
stroke, but it did increase by 67 percent the risk of death during follow-up.
The authors of the study said it wasn’t clear if the increased risk was the result of
antidepressants or depression itself. Depression is a known risk factor for cardiovascular
“There are a lot of things this study couldn’t tell us, such as whether this risk truly is
attributable to the drugs and not to depression itself and whether participants were being
treated for depression or for anxiety, which also has cardiovascular risks,” Jordan W. Smoller,
MD, ScD, of the Massachusetts General Hospital (MGH) Department of Psychiatry, the
study’s lead author, said in a press release. “We also don’t know whether there is any similar
association in younger women or in men, since they were not part of this study.”
The authors of the study called for more research into the relationship between
antidepressants and death.
Zoloft is prescribed to treat depression, anxiety, post-traumatic stress disorder and OCD
(obsessive compulsive disorders). It has also been used to treat extreme premenstrual
syndrome and sexual dysfunctions (premature ejaculation). Zoloft claims to work by restoring
the balance of chemicals within the brain.
Zoloft has a side effect which deadens sexual sensation, hence being prescribed for premature ejaculation. As the side effects continue
an erection also becomes difficult.
Psychiatrists agree: "If you were to just leave a patient alone and not prescribe Zoloft, the patient would be better in 4 to 12 weeks."
Zoloft prescribed for depression, anxiety, post-traumatic stress disorder also deadens the person where they can no longer feel.
Occasionally, >2 <75 Zoloft users will become agitated. The Zoloft agitation tends to persist until additional drugs are prescribed to
deaden the feelings further.
Zoloft - Alert from the F.D.A.
FDA ALERT [07/2005]: Suicidal Thoughts or Actions in Children and Adults
Patients with depression or other mental illnesses often think about or attempt suicide. Closely watch anyone taking antidepressants,
especially early in treatment or when the dose is changed. Patients who become irritable or anxious, or have new or increased
thoughts of suicide or other changes in mood or behavior (or their care givers) should contact their healthcare professional right away.
Taking antidepressants may increase suicidal thoughts and actions in about 1 out of 50 people 18 years or younger. FDA has approved
Zoloft for use in children only if they have obsessive-compulsive disorder.
Several recent scientific publications report the possibility of an increased risk for suicidal behavior in adults who are being treated with
antidepressant medications. Even before these reports became available, FDA began a complete review of all available data to
determine whether there is an increased risk of suicidal thinking or behavior in adults being treated with antidepressant medications. It
is expected that this review will take a year or longer to complete. In the meantime, FDA is highlighting that adults being treated with
antidepressant medication, particularly those being treated for depression, should be watched closely for worsening of depression and
for increased suicidal thinking or behavior.
This information reflects FDA’s preliminary analysis of data concerning this drug. FDA is considering, but has not reached a final
conclusion about, this information. FDA intends to update this sheet when additional information or analyses become available.